Antimicrobials Flashcards
Acyclovir
MOA: Inhibits viral replication by suppressing DNA synthesis Indications: - Topical: HSV - PO: HSV/VSV - IV: HSH/VSV in immunocompromised patients Adverse Effects: - IV phlebitis - Nephrotoxicity (increased BUN/creatinine) - Neurotoxicity Nursing Considerations: - Monitor IV site - Monitor renal & neuro status
Ganciclovir
MOA: Inhibits viral replication by suppressing DNA synthesis
Indications:
- CMV in immunocompromised patients
Adverse Effects:
- Bone Marrow Suppression: thrombocytopenia/granulocytopenia
- Teratogenicity
Nursing Considerations:
- Monitor CBC for changes in WBC & PLT
- Co-adminsiter with granulocyte colony-stimulating factor (GCSF)
- PO with food
- Use of contraception
Interferon Alfa
MOA: Interferes with... - Viral entry - Viral RNA & protein synthesis - Viral assembly/release Indications: - Hepatitis B Virus - Hepatitis C Virus Adverse Effects: - Flu-like s/s - Severe depression - Bone marrow suppression Nursing Considerations: - Monitor liver s/s & enzymes - Monitor mental status - Monitor CBC - Admin. acetaminophen for flu-like s/s
Ribavirin
MOA: Increases interferon alfa effects Indications: - Hepatitis C treatment along with interferon alfa Adverse Effects: - Flu-like s/s - Severe depression - Bone marrow suppression - Hemolytic anemia - Fetal injury! Nursing Considerations: - Monitor liver s/s & enzymes - Extended contraception use (60 days after tx) - Monitor mental status - Monitor CBC - Admin. acetaminophen for flu-like s/s - Caution with sulfa allergies!
Simeprevir
Protease Inhibitor MOA: Inhibits viral protease & replication Indications: - HCV Adverse Effects: - Headache, nausea, fatigue - Hepatic injury - Photosensitivity - Rash Nursing Considerations: - Monitor hepatitis s/s & liver enzymes - Caution with sulfa allergies!
Daclatasvir
NS5A Inhibitor MOA: Inhibits NS5A protein which is necessary for viral replication and assembly Indications: - HCV Adverse Effects: - Headache & fatigue - Possible anemia Nursing Considerations: - Monitor hepatitis s/s & liver enzymes - Numerous drug interactions!
Oseltamivir
MOA: Inhibits neuraminidase to prevent viral replication and prevents newly formed viral particles from spreading to other cells
Indications:
- Influenza virus
Adverse Effects:
- Generally well-tolerated
- N/V
- Hypersensitivity & neuropsychiatric (rare)
Nursing Considerations:
- Rapid flu testing
- Tx should be started 48-72 after onset of symptoms
- Monitor for allergic reactions
Abacavir
Nucleoside Reverse Transcriptase Inhibitor (NRTI) MOA: Acts as a substrate for reverse transcriptase to inhibit replication & DNA synthesis Indications: - HIV Adverse Effects: - Lactic Acidosis - Hepatic Steatosis - Hypersensitivity - Increase risk of MI Nursing Considerations: - Genetic Testing for hypersensitivity risk - Monitor LA, HA, & MI s/s
Efavirenz
Non-Nucleoside Reverse Transcriptase Inhibitor
MOA: Binds to active center of reverse transcriptase to prevent replication & DNA synthesis
Indications:
- HIV
Adverse Effects:
- CNS s/s
- Rash
- Teratogenicity
Nursing Considerations:
- Numerous drug interactions
- Take on empty stomach to reduce CNS effects
Lopinavir/Ritonavir
Protease Inhibitor MOA: Inhibits protease, an enzyme needed for HIV maturation; ritonavir boosts lopinavir effects Indications: - HIV Adverse Effects: - Diarrhea - Hyperglycemia & new-onset diabetes - Lipodystrophy & hyperlipidemia - Prolonged PR & QT interval Nursing Considerations: - Cardiac monitoring (telemetry) - Monitor glucose levels
Raltegravir
Integrase Strand Transfer Inhibitor (INSTI) MOA: inhibit integrase, an enzyme needed for HIV DNA insertion into host cell; prevents replication Indications: - HIV Adverse Effects: - Generally well-tolerated - Elevated liver enzymes - Hypersensitivity reactions - Resistance more common Nursing Considerations: - Assess for hepatic injury & trend LFT - Report skin manifestations & stop med immediately!
Enfuvirtide
Fusion inhibitor MOA: Inhibits HIV fusion into host cell; medication binds to lipid bilayer Indications: - HIV Adverse Effects: - SQ injection site reactions - Bacterial pneumonia - Hypersensitivity Nursing Considerations: - Administer SQ - Monitor respiratory & integumentary s/s
Maraviroc
CCR5 Antagonist
MOA: Inhibits CCR5, a co-receptor needed for HIV entry into host cell
Indications:
- HIV
Adverse Effects:
- Hepatic Injury
- Increased risk for CV-events (MI, CVA, etc.)
Nursing Considerations:
- Assess for liver injury
- Assess CV status
- CCR5 tropism assay may be performed to ensure that HIV strain is compatible with this medication
Hydroxychloroquine
Antimalarial & DMARD MOA: may interfere with binding of SARS-CoV-2 spike protein to the host cell by reducing glycosylation of ACE2 Indications: - SARS-CoV-2 FDA EUA (revoked June 2020) Adverse Effects: - Heart failure & cardiac dysrhythmias - Neuropsychiatric effects (hallucinations, psychosis, agitation, etc.) - Hemolytic anemia - Severe hypoglycemia - Skeletal muscle myopathy - Retinal Damage Nursing Considerations: - Baseline exam prior to starting tx - Baseline EKG - Monitor cardiac s/s - Monitor blood glucose
Remdesivir
IV SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor
MOA: Inhibits RNA polymerase; results in delayed chain termination during replication
Indications:
- COVID-19 infection requiring hospitalization
Adverse Effects:
- Elevated AST & ALT
- Hypersensitivity reactions (may be severe - anaphylaxis, etc.)
- Prolonged prothrombin time (PT)
Nursing Considerations:
- Monitor CMP & liver s/s
- Monitor renal function for impairment
- Discontinue infusion if hypersensitivity